Skip Navigation



NDT Advance Access published online on November 24, 2009
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp602
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koziolek, M. J.
Right arrow Articles by Strutz, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koziolek, M. J.
Right arrow Articles by Strutz, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure

Michael J. Koziolek1, Gerhard-Anton Müller1, Antonia Zapf2, Daniel Patschan1, Holger Schmid3, Clemens D. Cohen3, Stefan Koschnick1, Radovan Vasko1, Carsten Bramlage1 and Frank Strutz1

1 Department of Nephrology and Rheumatology, Georg-August University Göttingen, 37075 Göttingen, Germany 2 Department of Medical Statistics, Georg-August University, Göttingen, Germany 3 Nephrology Center, Ludwig-Maximilians University, Munich, Germany

Correspondence and offprint requests to: Michael J. Koziolek; E-mail: mkoziolek{at}med.uni-goettingen.de



  Abstract

Background. The chemokine/chemokine receptor pair CX3C-L/CX3C-R is suspected to play a role in renal fibrogenesis. The aim of this study was to investigate their function in an animal model of slowly progressive chronic renal failure.

Methods. Functional data were analysed in folic acid nephropathy (FAN) at different time points (up to day 142 after induction). Immunostaining for CX3C-L, CD3, S100A4, collagen type I, fibronectin, alpha-smooth muscle actin, Tamm-horsfall protein, aquaporin 1 and 2 as well as quantitative real-time PCR (qRT–PCR) for CX3C-L, CX3C-R and fibroblast-specific protein 1 (FSP-1) were performed. Additionally, regulatory mechanisms and functional activity of CX3C-L in murine proximal and distal tubular epithelial cells as well as in fibroblasts were investigated.

Results. CX3C-L/GAPDH ratio was upregulated in FAN 3.4-fold at day 7 further increasing up to 7.1-fold at day 106. The expression of mRNA CX3C-L correlated well with CX3C-R (R2 = 0.96), the number of infiltrating CD3+ cells (R2 = 0.60) and the degree of tubulointerstitial fibrosis (R2 = 0.56) and moderately with FSP-1 (R2 = 0.33). Interleukin-1β, tumour necrosis factor-{alpha}, transforming growth factor-β as well as the reactive oxygen species (ROS) H2O2 were identified by qRT–PCR as inductors of CX3C-L/fractalkine (FKN) in tubular epithelial cells. Functionally, CX3C-L/FKN chemoattracts peripheral blood mononuclear cells, activates several aspects of fibrogenesis and induces the mitogen-activated protein kinases in renal fibroblasts.

Conclusions. In FAN, there is a good correlation between the expression of CX3C-L with markers of interstitial inflammation and fibrosis which may result from upregulation by pro-inflammatory and pro-fibrotic cytokines as well as by ROS in tubular epithelial cells. The FKN system may promote renal inflammation and renal fibrogenesis.

Keywords: chronic renal failure; fibrosis; inflammation

Received for publication: 3. 2.09
Accepted in revised form: 20.10.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.